WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 61'6001 Infant (under 12 months) mortality rate: 22
GDP / capita (US$): 45'1441 Child (under 5 years) mortality rate: 32

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 9'631  9'571  9'511  9'449  9'382  8'872  8'559  8'311 
Births 116  115  114  113  112  91  117  93 
Surviving infants 116  115  114  113  112  91  116  93 
Pop. less than 5 years 578  571  565  560  555  463  553  487 
Pop. less than 15 years 1'651  1'619  1'588  1'563  1'549  1'635  1'535  1'628 
Female 15-49 years 2'124  2'128  2'131  2'130  2'122  1'982  2'048  1'902 

Number of reported case

(Click for retrospective incidence data for Sweden)
Diphtheria
Japanese encephalitis
Measles 26  51  30  26  59  29  1'786 
Mumps 21  44  33  38  24  37 
Pertussis 703  237  289  177  266  2'705  10'697  5'221 
Polio*
Rubella 50 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Sweden)
Vaccine year result method % card seen                                                
BCG          26  27  24  23  23  16  13 
DTP1         
DTP3          98  98  98  98  98  99  99 
DTP4         
IPV1         
HepB_BD         
HepB3          42  35  30  29  27 
Hib3          98  98  98  98  98  98 
JapEnc         
MCV1          97  97  97  96  97  91  96  88 
MCV2          95  95  95  95  94  94 
PCV1         
PCV3          98  98  98  60 
Pol3          98  98  98  98  98  99  99  97 
Rota1         
Rota_last         
Rubella1          97  97  97  96  97 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Sweden)
BCG 26  26  26  26  27  16  13 
DTP1 99  99  99  99  99  99  99  99 
DTP3 98  98  98  98  98  99  99  99 
HepB3 42  42  42  42 
HepB_BD
Hib3 98  98  98  98  98  98 
MCV1 97  97  97  97  97  91  96  88 
MCV2 95  95  95  95  94  94 
PCV3 98  98  98  98  98 
Pol3 98  98  98  98  98  99  99  97 
Rota_last

Number of districts in the country 290  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90% 98
From 80 to 89% 2
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth-6 months; Yes risk groups
DTaPHibHepIPV 3, 5, 12 months; Yes risk groups HB (except children to HBsAg+ mothers)
DTaPHibIPV 3, 5, 12 months; Yes
DTaPIPV 5-6 years; Yes
HPV 10-12 years (x3); Yes girls
HepB birth; 1, 3, 5, 12 months; Yes Children to HBsAg+ mothers
Influenza_Adult >= 65 years; Yes pregnant women, adults with chronic diseases
Influenza_Pediatric Yes children with chronic diseases
MMR 18 months; 6-8 years; Yes
Pneumo_conj 3, 5, 12 months; Yes
Pneumo_ps > 65 years; No + medical risk groups
Rotavirus No Introduced in 2/21 counties
Tdap 14-16 years; Yes Children born from 2002; From 2016

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  No  No  No  NA 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number         NA  NA   

System performance

Total Nº districts in country number 290  290  290  290  290  290  290 
Nº districts with DTP3 coverage >=80% number 290  290  290  290  290  289  290 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 263  267  251  244  252  251  234 
% of districts with MCV1 coverage >=95% From 0 to 100% 91  92  87  84  87  87  81 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100%           NA  NA 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.